Biotech · Private company
OncoVerity, Inc.
Track this companyFree. Adds OncoVerity, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- AzacitidinePhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- CusatuzumabPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 2 · Leukemia, Myeloid, AcuteClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive TherapyPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 22, 2024ClinicalTrials.gov NCT06384261 · fetched Nov 12, 2026
- Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid LeukemiaPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 23, 2019ClinicalTrials.gov NCT04150887 · fetched Nov 12, 2026